when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

AdCom · news · pharmadog

← back to AdCom

News · AdCom

169 stories

Sep 4, 26FDA Grants Accelerated Approval to a New Breast Cancer Treatmentfda press

Sep 4, 26Disabled workers at greater risk of losing health insurancestat

Sep 3, 26HHS flip-flops on disability lawsuitstat

Sep 3, 26Replimune’s melanoma drug would have been rejected again if not for senior CBER officialbiospace

Sep 3, 26Capricor, Replimune illustrate why FDA must listen to rare disease specialistsbiospace

Sep 2, 26Doctors groups release vaccination guidelines ahead of respiratory illness seasonstat

Sep 2, 26HHS spins a tale of a would-be content creator childstat

Sep 1, 26GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalitybiospace

Sep 1, 26Paxlovid did not help long Covid, study findsstat

Aug 31, 26A winner, a loser, and a mid-stage signal from a major cardiology research conferencestat

Aug 29, 26STAT+: A Novartis drug cut inflammation. Can it improve heart outcomes?stat

Aug 28, 26Juul gets OK to sell updated vaping device with age-gating technologystat

Aug 28, 26At a federal autism advisory committee meeting, members double down on long-debunked theoriesstat

Aug 28, 26STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugsstat

Aug 28, 26Opinion: We quit the CDC last year. The problems we protested remainstat

Aug 28, 26Vaccines take center stage at federal autism advisory committeestat

Aug 27, 26RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute thatstat

Aug 26, 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedbiospace

Aug 25, 26Capricor secures reprieve as FDA extends DMD cell therapy reviewfiercebiotech

Aug 24, 26Capricor’s Duchenne therapy has new life after FDA grants 3-month extensionbiospace

Aug 24, 26Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alonebiospace

Aug 21, 26Capricor investor calls for change as company awaits decision on Duchenne candidatebiospace

Aug 20, 26Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a studystat

Aug 19, 26Trump picks White House aide Heidi Overton as FDA chief: Reportsbiospace

Aug 19, 26Physician group sues Trump administration over dietary guidelines processstat

Aug 14, 26Capricor, seeking lifeline for Duchenne therapy, says it will ask FDA to review additional dataendpoints

Aug 14, 26Capricor soars on potential FDA review extension, filing amendmentsbiospace

Aug 14, 26Capricor soars on plan to amend DMD filing after adcomm setbackfiercebiotech

Aug 12, 26Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlightbiospace

Aug 10, 26STAT+: FDA panel to weigh Grail’s Galleri teststat

← prevpage 2 of 6next →